尿激酶纤溶酶原激活物,urokinase-type plasminogen activator英语短句,例句大全

尿激酶纤溶酶原激活物,urokinase-type plasminogen activator
1)urokinase-type plasminogen activator尿激酶纤溶酶原激活物
1.Aim: To investigate the expression of urokinase-type plasminogen activator (uPA) in human colorectal carcinoma tissue and its relation to the neovascularization.目的检测大肠癌组织中尿激酶纤溶酶原激活物(uPA)及微血管密度(MVD)。
2.The protein level of urokinase-type plasminogen activator (uPA) was also determined by western blotting.采用Western blot方法检测癌细胞尿激酶纤溶酶原激活物(uPA)蛋白水平。
3.Besides,the protein level of urokinase-type plasminogen activator(uPA) was also determined by Western blot assay.另外,采用Western blot方法检测癌细胞尿激酶纤溶酶原激活物(urokinase-type plasminogen activator,uPA)蛋白变化。
2)urinary plasminogen activator尿纤溶酶原激活物

英文短句/例句

1.The Climical Significance and Expression of Urinary Plasminogen Activator in Breast Cancer尿纤溶酶原激活物在乳腺良恶性组织中的表达及意义
2.Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
3.The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
4.Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
5.Study on the Transcriptional Regulation of Urokinase Plasminogen Activator in Human Lung Cancer;尿激酶型纤溶酶原激活物在人肺癌细胞中表达调控的研究
6.The Experiment Research That the uPA to Suffer from the Relativity with the Arthritis Disease;尿激酶型纤溶酶原激活物（uPA）与关节炎性疾患相关性的实验研究
7.Expressions of Survivin and uPA in human cerebral gliomas脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达
8.Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
9.Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;重组非糖基化尿激酶型纤溶酶原激活剂的研究
10.Effects of Qinggan Huoxue Recipe and its separated recipes on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 fibrinolytic system in rats with alcoholic liver fibrosis清肝活血方及其拆方对酒精性肝纤维化大鼠尿激酶型纤溶酶原激活物途径的影响
11.Research Progress of Plasminogen Activator Inhibitor One in Gestational Diabetes Mellitus纤溶酶原激活物抑制剂-1（PAI-1）与妊娠期糖尿病的研究
12.Detection and clinical significance of plasma urokinase-type plasminogen activator and its soluble receptor in multiple myeloma patients;多发性骨髓瘤患者血浆尿激酶型纤溶酶原激活物及其可溶性受体的检测
13.A Study of the Level of Cyclooxygenase-2 and Urokinase-type Plasminogen Activator in the Left and Right Atrium of Acute Atrial Fibrillation in Canines;犬急性心房颤动时心房环氧酶-2与尿激酶型纤溶酶原激活物的变化
14.Cloning and Expression of Urokinase Type Plasminogen Activator cDNA尿激酶型纤溶酶原激活因子cDNA的克隆与原核表达
15.Significance of Urokinase-type Plasminogen Activator and Urokinase-type Plasminogen Activator Receptor in Synovial Fluid of Patients with Temporomandibular Disorders;颞下颌关节紊乱病关节液中尿激酶型纤溶酶原激活物及其受体的检测
16.The Effect of Amiloride-an Inhibitor of Urokinase on the Pathology of Rat COPD Model;尿激酶型纤溶酶原激活物抑制剂—氨氯吡咪对大鼠COPD模型病理改变的影响
17.The Expression of uPA and Endostatin in Human Colorectal Carcinoma and Their Relations to Angiogenesis;人大肠肿瘤中尿激酶型纤溶酶原激活物和内皮抑素的表达与血管新生的关系
18.The Preliminary Research of the Effect of External Urokinase-type Plasminogen Activator(uPA) to the Synovial Tissue of Rabbits Keen Joint;外源性尿激酶型纤溶酶原激活物（uPA）对兔膝关节滑膜影响的初步研究